U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 2C10H9O2.2C2H5O.Ti
Molecular Weight 460.343
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge -4

SHOW SMILES / InChI
Structure of BUDOTITANE

SMILES

[Ti].CC[O-].CC[O-].CC(=O)[CH-]C(=O)C1=CC=CC=C1.CC(=O)[CH-]C(=O)C2=CC=CC=C2

InChI

InChIKey=KAPHMPHWLCJRRK-UHFFFAOYSA-N
InChI=1S/2C10H9O2.2C2H5O.Ti/c2*1-8(11)7-10(12)9-5-3-2-4-6-9;2*1-2-3;/h2*2-7H,1H3;2*2H2,1H3;/q4*-1;

HIDE SMILES / InChI

Molecular Formula Ti
Molecular Weight 47.867
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C10H10O2
Molecular Weight 162.1852
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C2H5O
Molecular Weight 45.0605
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Budotitane [cis-diethoxybis(1-phenylbutane-1,3-dionato)titanium (IV)] is an inorganic titanium complex. The complex acts as a DNA intercalating agent thereby affecting cell proliferation. Preclinical studies in established screening models indicate considerable antitumor activity. Budotitane reached the end of phase I clinical trials for the treatment of solid tumors.

Approval Year

PubMed

PubMed

TitleDatePubMed
Clinical phase I and pharmacokinetic trial of the new titanium complex budotitane.
1996

Sample Use Guides

Phase I trial dose levels ranged from 100 mg/m2 to 230 mg/m2 twice weekly. Using this schedule, 180 mg/m2 is a safe dose for subsequent clinical studies.
Route of Administration: Intravenous
Substance Class Chemical
Created
by admin
on Sat Dec 16 16:04:45 GMT 2023
Edited
by admin
on Sat Dec 16 16:04:45 GMT 2023
Record UNII
DV05VZD83V
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BUDOTITANE
INN  
INN  
Official Name English
DIETHOXYBIS(1-PHENYL-1,3-BUTANEDIONATO)TITANIUM
Common Name English
budotitane [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C274
Created by admin on Sat Dec 16 16:04:45 GMT 2023 , Edited by admin on Sat Dec 16 16:04:45 GMT 2023
Code System Code Type Description
INN
5990
Created by admin on Sat Dec 16 16:04:45 GMT 2023 , Edited by admin on Sat Dec 16 16:04:45 GMT 2023
PRIMARY
NCI_THESAURUS
C81555
Created by admin on Sat Dec 16 16:04:45 GMT 2023 , Edited by admin on Sat Dec 16 16:04:45 GMT 2023
PRIMARY
MESH
C043899
Created by admin on Sat Dec 16 16:04:45 GMT 2023 , Edited by admin on Sat Dec 16 16:04:45 GMT 2023
PRIMARY
SMS_ID
100000088454
Created by admin on Sat Dec 16 16:04:45 GMT 2023 , Edited by admin on Sat Dec 16 16:04:45 GMT 2023
PRIMARY
EPA CompTox
DTXSID70235302
Created by admin on Sat Dec 16 16:04:45 GMT 2023 , Edited by admin on Sat Dec 16 16:04:45 GMT 2023
PRIMARY
PUBCHEM
359472
Created by admin on Sat Dec 16 16:04:45 GMT 2023 , Edited by admin on Sat Dec 16 16:04:45 GMT 2023
PRIMARY
FDA UNII
DV05VZD83V
Created by admin on Sat Dec 16 16:04:45 GMT 2023 , Edited by admin on Sat Dec 16 16:04:45 GMT 2023
PRIMARY
EVMPD
SUB05957MIG
Created by admin on Sat Dec 16 16:04:45 GMT 2023 , Edited by admin on Sat Dec 16 16:04:45 GMT 2023
PRIMARY
CAS
85969-07-9
Created by admin on Sat Dec 16 16:04:45 GMT 2023 , Edited by admin on Sat Dec 16 16:04:45 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE